Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong.

Chan, Thomas Sau-Yan; Cheng, Sally Shuk-Yee; Chen, Wei-Ting; Hsu, Danny Chung; Chau, Rene Wing-Yan; Kang, Suk Hyun; Alsumali, Adnan; Kwong, Yok-Lam

Chan, Thomas Sau-Yan; Cheng, Sally Shuk-Yee; Chen, Wei-Ting; Hsu, Danny Chung; Chau, Rene Wing-Yan; Kang, Suk Hyun; Alsumali, Adnan; Kwong, Yok-Lam.

Afiliación

Chan TS; Department of Medicine, Queen Mary Hospital, Hong Kong, China.
Cheng SS; Global Medical & Scientific Affairs, MSD, Hong Kong, Hong Kong.
Chen WT; Global Medical & Scientific Affairs, MSD, Taipei, Taiwan.
Hsu DC; Global Medical & Scientific Affairs, MSD, Hong Kong, Hong Kong.
Chau RW; Global Medical & Scientific Affairs, MSD, Hong Kong, Hong Kong.
Kang SH; Centre for Observational and Real-world Evidence, MSD, Seoul, Korea.
Alsumali A; Merck & Co., Inc., Kenilworth, NJ, USA.
Kwong YL; Department of Medicine, Queen Mary Hospital, Hong Kong, China.

J Med Econ ; 23(12): 1485-1492, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33155494

Asunto(s)

Citomegalovirus; Trasplante de Células Madre Hematopoyéticas; Acetatos; Adulto; Antivirales/uso terapéutico; Análisis Costo-Beneficio; Trasplante de Células Madre Hematopoyéticas/efectos adversos; Hong Kong; Humanos; Quinazolinas

Palabras clave

Allogenic hematopoietic stem cell transplantation; Hong Kong; I10; I18; cost effectiveness analysis; cytomegalovirus; letermovir

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Citomegalovirus Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: J Med Econ Asunto de la revista: SERVICOS DE SAUDE Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google